Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osseous tissue engineering in oncologic surgery.

M J Miller1

  • 1Department of Plastic Surgery, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA. mmiller@manderson.org

Seminars in Surgical Oncology
|January 3, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antigenic cross-reactivity of venoms from medically important North American Loxosceles spider species.

Toxicon : official journal of the International Society on Toxinology·2001
Same author

Ecology of Borrelia burgdorferi in ticks (Acari: Ixodidae), rodents, and birds in the Sierra Nevada foothills, Placer County, California.

Journal of medical entomology·2000
Same author

Cellular dissociation of NF-kappaB and inducible nitric oxide synthase in Helicobacter pylori infection.

Free radical biology & medicine·2000
Same author

Detection of Loxosceles venom in lesional hair shafts and skin: application of a specific immunoassay to identify dermonecrotic arachnidism.

The American journal of emergency medicine·2000
Same author

Recurrent hypoxic exposure and reflex responses during development in the piglet.

Respiration physiology·2000
Same author

Acute excitotoxic injury induces expression of monocyte chemoattractant protein-1 and its receptor, CCR2, in neonatal rat brain.

Experimental neurology·2000
Same journal

Preoperative chemoradiation for locally advanced rectal cancer: rationale, technique, and results of treatment.

Seminars in surgical oncology·2003
Same journal

Preoperative chemoradiation for locally advanced rectal adenocarcinoma-the University of Florida experience.

Seminars in surgical oncology·2003
Same journal

Postoperative adjuvant therapy for pancreatic cancer.

Seminars in surgical oncology·2003
Same journal

Conformal chemoradiation for primary and metastatic liver malignancies.

Seminars in surgical oncology·2003
Same journal

Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer.

Seminars in surgical oncology·2003
Same journal

Combined modality therapy in esophageal cancer: the Memorial experience.

Seminars in surgical oncology·2003
See all related articles

Tissue engineering offers new bone sources for cancer research and treatment. Advances in biomaterials, cell technology, and gene manipulation are key to clinical applications in oncology.

Area of Science:

  • Oncology
  • Tissue Engineering
  • Biomaterials Science

Background:

  • Tissue engineering is an emerging interdisciplinary field with significant potential in oncology.
  • Bone tissue regeneration is a primary focus within this field.
  • Progress relies on advancements in multiple scientific domains.

Purpose of the Study:

  • To explore the role and advancements of tissue engineering in oncology.
  • To highlight key areas of progress relevant to clinical applications.
  • To outline the goals of tissue engineering in cancer research and patient care.

Main Methods:

  • Review of progress in advanced computing, biomaterials, cell technology, growth factor fabrication and delivery, and gene manipulation.
  • Assessment of the translation pathway from research to clinical practice, including industrial scale-up and regulatory approval.

Related Experiment Videos

  • Identification of current challenges and future directions.

    • Main Results:

    • Significant progress has been made in core areas such as biomaterials and cell technology.
    • The development of clinical techniques is anticipated with continued research.
    • Scaling up innovations for industrial production and regulatory clearance is crucial.

    Conclusions:

    • Tissue engineering holds promise for developing improved tissue models for basic cancer research.
    • It is expected to drive changes in clinical practice for oncology patients.
    • Successful translation requires interdisciplinary collaboration and regulatory compliance.